Structural Formula For Carvedilol (Image 1)
Chemical structure diagram of Carvedilol, showing molecular connections and functional groups in the compound.*
Carvedilol Tablet, Film Coated
Product Images NDC 50090-7890
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 50090-7890). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Fig 1 (Image 2)
A Kaplan-Meier survival graph showing percent mortality over 24 months, comparing Carvedilol treatment to placebo. The y-axis represents percent mortality, ranging from 0 to 30%, and the x-axis shows time in months. The Carvedilol curve lies consistently below the placebo curve, indicating lower mortality with Carvedilol. A p-value of 0.0014 is noted on the chart.*
Fig 2 (Image 3)
A forest plot showing hazard ratios with confidence intervals for various patient subgroups, including sex, age, race, diabetic status, ischemic status, heart rate, systolic blood pressure, and spironolactone use. The x-axis is labeled 'Hazard ratio' ranging from 0.0 to 2.0. Each subgroup is listed on the y-axis with corresponding plotted points and horizontal lines representing confidence intervals, with a vertical dashed line at 1.0 to indicate the no-effect threshold.*
Fig 3 (Image 4)
A line graph showing percent mortality over a 24-month period comparing Carvedilol treatment to placebo. The x-axis represents months and the y-axis shows mortality percentage. Two lines indicate higher mortality in the placebo group relative to Carvedilol, with a P-value of 0.03 noted on the graph.*
Fig 4 (Image 5)
A chart showing hazard ratio data for various patient subgroups related to a cardiovascular drug study. The data points with confidence intervals compare hazard ratios for factors like age, gender, timing post-myocardial infarction, medication use, heart conditions, comorbidities, and patient vitals. The x-axis measures hazard ratios ranging roughly from 0.4 to 1.3 with a reference line at 1.0.*
Label Image (Lbl500907890)
Carvedilol 3.125 mg film-coated tablets packaging label from A-S Medication Solutions, containing 90 tablets. The label includes storage instructions to keep the product at 68 to 77 degrees Fahrenheit, protected from moisture. The product NDC is 50090-7890.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
